Furthermore, CD36 overexpression has been associated with faster tumor growth, cancer progression, and metastasis initiation (Pascual et al., 2017; Luo et al., 2021; Guerrero-Rodriguez et al., 2022; Ruan et al., 2022). Here, CD36 is linked to neoplasm.